BioAge Labs’ $238 Million Upsized Initial Public Offering

Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters.BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here